what is tirzepatide called First Time F.D.A. Approves New Obesity Drug

Description

Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools

This FDA-approved medication works primarily through appetite suppression and enhanced satiety, leading to reduced caloric intake and subsequent fat mobilization

Keeping your Mounjaro pen in a visible location, like your kitchen counter, can serve as a visual reminder

We further examined whether acute tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist recently approved by the FDA for obesity, and retatrutide, an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors currently in Phase 3 trials would recapitulate or enhance these effects